NIH begins first-in-human trial of a universal influenza vaccine candidate

Date posted
Funding Agency
(Funded by the National Institutes of Health)

Scientists have started the first clinical trial of an innovative universal influenza vaccine candidate that uses nanoparticles. The clinical trial is examining the vaccine’s safety and tolerability as well as its ability to induce an immune response in healthy volunteers.